个体化行为干预对肝癌介入术后患者康复及预防并发症发生的影响
|
摘要
目的探讨个体化行为干预对肝癌介入术后患者康复及预防并发症发生的影响。方法选取2015年1月～2017年6月行肝癌行介入治疗患者80例,随机分为观察组与对照组,对照组予以常规治疗与康复,观察组在此基础上予以个体化行为干预,两组均干预3个月,观察并比较两组患者术后康复及并发症发生情况。结果干预3个月后,两组生活质量的生理状态、心理状态、情绪角色、社会功能四个维度评分均较干预前改善(P<0.05或P<0.01),且观察组改善情况更明显(P<0.05);随访3个月,观察组术后并发症发生率明显低于对照组(P<0.05)。结论个体化行为干预肝癌介入术后患者有助于患者术后的康复,提高患者术后生活质量,减少术后并发症的发生。
Objective To investigate the effect of individualized behavioral intervention on the rehabilitation and prevention of complications in the patients after liver cancer intervention. Methods A total of 80 patients who were given interventional therapy of liver cancer from January 2015 to June 2017 were selected and randomly divided into observation group and control group. The control group was given routine treatment and rehabilitation. On the basis of this,the observation group was given individualized behavioral intervention. Both groups were intervened for 3 months. The postoperative rehabilitation and complications of the two groups were observed and compared. Results After 3 months of intervention, the scores of the four dimensions of quality of life, including physiological state, mental state, emotional role and social function of the two groups were improved compared with those before intervention(P<0.05 or P<0.01).The improvement in the observation group was more significant(P<0.05); after 3 months of follow-up, the incidence rate of postoperative complications was significantly lower in the observation group than that in the control group(P<0.05).Conclusion Individualized behavioral intervention for the patients after liver cancer intervention can help patients' recover after surgery, improve postoperative quality of life and reduce postoperative complications.
Objective To investigate the effect of individualized behavioral intervention on the rehabilitation and prevention of complications in the patients after liver cancer intervention. Methods A total of 80 patients who were given interventional therapy of liver cancer from January 2015 to June 2017 were selected and randomly divided into observation group and control group. The control group was given routine treatment and rehabilitation. On the basis of this,the observation group was given individualized behavioral intervention. Both groups were intervened for 3 months. The postoperative rehabilitation and complications of the two groups were observed and compared. Results After 3 months of intervention, the scores of the four dimensions of quality of life, including physiological state, mental state, emotional role and social function of the two groups were improved compared with those before intervention(P<0.05 or P<0.01).The improvement in the observation group was more significant(P<0.05); after 3 months of follow-up, the incidence rate of postoperative complications was significantly lower in the observation group than that in the control group(P<0.05).Conclusion Individualized behavioral intervention for the patients after liver cancer intervention can help patients' recover after surgery, improve postoperative quality of life and reduce postoperative complications.
引文
[1]唐玉霞,金慧英,夏雨虹,等.炎性细胞因子检测在原发性肝癌患者预测及分期中的临床价值[J].中华全科医学,2017,15(9):1546-1548.
[2]滕建军.原发性肝癌的发病危险因素分析[J].中华肿瘤防治杂志,2016,23(S1):162-163.
[3]张雪松,王魁阳,王利菊,等.肝动脉化疗栓塞术联合贝伐单抗治疗老年晚期原发性肝癌的疗效[J].中国老年学杂志,2018,38(8):1828-1829.
[4]Sapisochin G,Barry A,Doherty M,et al.Stereotactic body radiotherapy vs.TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma.An intention-to-treat analysis[J].J Hepatol,2017,67(1):92-99.
[5]Tssimberidou AM,Vaklavas C,Fu S,et al.Hepatic arterial infusion therapy in advanced cancer And liver-predominant disease:the MD anderson experience[J].Hepatoqastroenterology,2013,60(127):1611-1623.
[6]胡芳,周霞.基于跨理论模型的动机访谈对肝癌介入术后患者并发症及自我管理行为的影响[J].中国地方病防治杂志,2017,32(5):573-576.
[7]武和平,刘亚民,李雅萍,等.肝癌介入手术患者术后并发症的临床分析[J].实用癌症杂志,2015,30(10):1490-1492.
[8]丛文铭,步宏,陈杰,等.原发性肝癌规范化病理诊断指南(2015版)[J].解放军医学杂志,2015,40(11):865-872.
[9]康文,向邦德,黄山,等.原发性肝癌患者围手术期乙型肝炎病毒DNA的变化及其影响因素[J].中华肝胆外科杂志,2013,19(9):681-685.
[10]祝葆华,万崇华,王坤,等.FLIC、SF-36和QOL-LC量表在肝癌患者生活质量测定中的应用比较[J].中国循证医学杂志,2012,12(10):1175-1179.
[11]Kiichi Sugimoto,Kazuhiro Sakamoto,Yuichi Tomiki,et al.Prognostic factors after palliative Resection for colorectal cancer with incurable synchronous liver metastasis[J].Open Journal of Gastroenterology,2013,3(5):15-17.
[12]Jin W,Han H,Zhou S,et al.Therapeutic efficacy of brucea javanica oil emulsion(BJOE)combined with transcatheter hepaticarterial chemoembolization(TACE)in patients with primary liver cancer[J].Int J Clin Exp Med,2015,8(10):18954-18962.
[13]侯倩倩,王大庆,肖杨,等.热化疗联合介入栓塞治疗中晚期原发性肝癌患者的疗效[J].中国肝脏病杂志(电子版),2016,8(4):39-43.
[14]廖爱民,刘友新,易军,等.肝动脉化疗栓塞治疗晚期肝癌的疗效及对肿瘤血管新生和肝纤维化指标的影响[J].临床和实验医学杂志,2017,16(16):1632-1635.
[15]杨璞,朱建华,肖文华,等.中晚期癌症患者支持治疗需求及影响因素分析[J].解放军医学院学报,2016,37(5):452-456.
[16]郑敏.早期进食对肝癌介入栓塞手术后患者降低并发症的临床观察[J].中国肿瘤临床与康复,2013,20(6):648-650.
[17]李毅,苏红.精准肝动脉化疗栓塞对原发性肝癌患者肝功能及并发症的影响[J].解放军预防医学杂志,2017,35(6):632-635.
[18]邹桂成,谭富阳.个体化行为干预治疗老年女性压力性尿失禁200例[J].中国中西医结合外科杂志,2016,22(4):388-391.
[19]田永丽.行为干预对宫颈癌根治术后尿失禁患者生活质量的影响[J].实用妇科内分泌电子杂志,2015,1(6):64-65.
[20]Elliott JO,Ortman C,Almassni S,et al.Understanding the associations between modifying Factors,individual health beliefs,and hemodialysis patients'aderence to a low-phosphorus diet[J].J Ren Nutr,2015,25(2):111-120.
[21]杨瑞萍,位秀丽,刘艳清,等.晚期肝癌患者主要照顾者的负担、焦虑和抑郁现状及影响因素分析[J].湖北医药学院学报,2018,37(1):59-64.
[22]曹雪晴,殷荣华,刘惠.肝癌介入术后患者肝癌支持性照顾需求及影响因素分析[J].预防医学,2018,30(1):59-62.
[2]滕建军.原发性肝癌的发病危险因素分析[J].中华肿瘤防治杂志,2016,23(S1):162-163.
[3]张雪松,王魁阳,王利菊,等.肝动脉化疗栓塞术联合贝伐单抗治疗老年晚期原发性肝癌的疗效[J].中国老年学杂志,2018,38(8):1828-1829.
[4]Sapisochin G,Barry A,Doherty M,et al.Stereotactic body radiotherapy vs.TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma.An intention-to-treat analysis[J].J Hepatol,2017,67(1):92-99.
[5]Tssimberidou AM,Vaklavas C,Fu S,et al.Hepatic arterial infusion therapy in advanced cancer And liver-predominant disease:the MD anderson experience[J].Hepatoqastroenterology,2013,60(127):1611-1623.
[6]胡芳,周霞.基于跨理论模型的动机访谈对肝癌介入术后患者并发症及自我管理行为的影响[J].中国地方病防治杂志,2017,32(5):573-576.
[7]武和平,刘亚民,李雅萍,等.肝癌介入手术患者术后并发症的临床分析[J].实用癌症杂志,2015,30(10):1490-1492.
[8]丛文铭,步宏,陈杰,等.原发性肝癌规范化病理诊断指南(2015版)[J].解放军医学杂志,2015,40(11):865-872.
[9]康文,向邦德,黄山,等.原发性肝癌患者围手术期乙型肝炎病毒DNA的变化及其影响因素[J].中华肝胆外科杂志,2013,19(9):681-685.
[10]祝葆华,万崇华,王坤,等.FLIC、SF-36和QOL-LC量表在肝癌患者生活质量测定中的应用比较[J].中国循证医学杂志,2012,12(10):1175-1179.
[11]Kiichi Sugimoto,Kazuhiro Sakamoto,Yuichi Tomiki,et al.Prognostic factors after palliative Resection for colorectal cancer with incurable synchronous liver metastasis[J].Open Journal of Gastroenterology,2013,3(5):15-17.
[12]Jin W,Han H,Zhou S,et al.Therapeutic efficacy of brucea javanica oil emulsion(BJOE)combined with transcatheter hepaticarterial chemoembolization(TACE)in patients with primary liver cancer[J].Int J Clin Exp Med,2015,8(10):18954-18962.
[13]侯倩倩,王大庆,肖杨,等.热化疗联合介入栓塞治疗中晚期原发性肝癌患者的疗效[J].中国肝脏病杂志(电子版),2016,8(4):39-43.
[14]廖爱民,刘友新,易军,等.肝动脉化疗栓塞治疗晚期肝癌的疗效及对肿瘤血管新生和肝纤维化指标的影响[J].临床和实验医学杂志,2017,16(16):1632-1635.
[15]杨璞,朱建华,肖文华,等.中晚期癌症患者支持治疗需求及影响因素分析[J].解放军医学院学报,2016,37(5):452-456.
[16]郑敏.早期进食对肝癌介入栓塞手术后患者降低并发症的临床观察[J].中国肿瘤临床与康复,2013,20(6):648-650.
[17]李毅,苏红.精准肝动脉化疗栓塞对原发性肝癌患者肝功能及并发症的影响[J].解放军预防医学杂志,2017,35(6):632-635.
[18]邹桂成,谭富阳.个体化行为干预治疗老年女性压力性尿失禁200例[J].中国中西医结合外科杂志,2016,22(4):388-391.
[19]田永丽.行为干预对宫颈癌根治术后尿失禁患者生活质量的影响[J].实用妇科内分泌电子杂志,2015,1(6):64-65.
[20]Elliott JO,Ortman C,Almassni S,et al.Understanding the associations between modifying Factors,individual health beliefs,and hemodialysis patients'aderence to a low-phosphorus diet[J].J Ren Nutr,2015,25(2):111-120.
[21]杨瑞萍,位秀丽,刘艳清,等.晚期肝癌患者主要照顾者的负担、焦虑和抑郁现状及影响因素分析[J].湖北医药学院学报,2018,37(1):59-64.
[22]曹雪晴,殷荣华,刘惠.肝癌介入术后患者肝癌支持性照顾需求及影响因素分析[J].预防医学,2018,30(1):59-62.